Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)

被引：0
|
作者：
Ho, Allen C. [1 ,2 ]
Banin, Eyal [3 ]
Barak, Adiel [4 ]
Boyer, David S. [5 ]
Ehrlich, Rita [6 ]
Jaouni, Tareq [7 ]
MacDonald, H. Richard [8 ]
Riemann, Christopher D. [9 ]
Telander, David [10 ]
Mones, Jordi [11 ,12 ]
Ben Shabat, Avi [13 ]
Hogge, Gary S. [14 ]
Reubinoff, Benjamin [15 ,16 ]
机构：
[1] Wills Eye Hosp & Res Inst, Philadelphia, PA USA
[2] Mid Atlantic Retina, Philadelphia, PA USA
[3] Hadassah Med Ctr, Dept Ophthalmol, Jerusalem, Israel
[4] Tel Aviv Sourasky Med Ctr, Ophthalmol, Tel Aviv, Israel
[5] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[6] Rabin Med Ctr, Ophthalmol Div Beilinson & Hasharon, Petah Tiqwa, Israel
[7] Hadassah Med Ctr, Dept Ophthalmol, Jerusalem, Israel
[8] West Coast Retina Grp, San Francisco, CA USA
[9] Cincinnati Eye Inst, Cincinnati, OH USA
[10] Retinal Consultants Med Grp, Sacramento, CA USA
[11] Inst Macula, Ophthalmol, Barcelona, Spain
[12] Barcelona Macula Fdn, Barcelona, Spain
[13] Lineage Cell Therapeut Inc, Cell Cure Neurosci, Jerusalem, Israel
[14] Lineage Cell Therapeut Inc, Carlsbad, CA USA
[15] Hadassah Med Ctr, Ctr Embryon Stem Cells, Jerusalem, Israel
[16] Hadassah Med Ctr, Dept Gynecol & Obstet, Jerusalem, Israel
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1862
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase I/IIa Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD): Interim Results
    Riemann, Christopher D.
    Banin, Eyal
    Barak, Adiel
    Boyer, David S.
    Ehrlich, Rita
    Ho, Allen
    Jaouni, Tareq
    McDonald, Richard
    Telander, David
    Mones, Jordi
    Velez, Joyce
    Hogge, Gary S.
    Reubinoff, Benjamin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [2] Phase I/IIa clinical trial of human embryonic stem cell (hESC)-derived retinal pigmented epithelium (RPE, OpRegen®) transplantation in advanced dry form age-related macular degeneration (AMD): interim results
    Banin, Eyal
    Hemo, Yitzchak
    Jaouni, Tareq
    Marks-Ohana, Devora
    Stika, Shelly
    Zheleznykov, Svetlana
    Obolensky, Alexey
    Gurevich, Maria
    Irving, Charles S.
    Reubinoff, Benjamin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [3] Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results
    Riemann, Christopher D.
    Banin, Eyal
    Barak, Adiel
    Boyer, David S.
    Ehrlich, Rita
    Jaouni, Tareq
    McDonald, Richard
    Telander, David
    Keane, Michael
    Ackert, Jessica
    Ferguson, Mark D.
    Ben-Shabat, Avi
    Mones, Jordi
    Angelini, Diana
    Hogge, Gary S.
    Reubinoff, Benjamin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [4] Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, Opregen®) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results
    Banin, Eyal
    Hemo, Yitzchak
    Jaouni, Tareq
    Marks-Ohana, Devora
    Gurevich, Maria
    Cuzzani, Oscar
    Boyer, David S.
    Reubinoff, Benjamin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results
    Banin, Eyal
    Barak, Adiel
    Boyer, David S.
    Do, Diana V.
    Ehrlich, Rita
    Jaouni, Tareq
    McDonald, Richard
    Tealander, David G.
    Gurevich, Maria
    Cohen, Ohad
    Razag, Ghesal
    Hogge, Gary S.
    Reubinoff, Benjamin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [6] One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration
    Kashani, Amir H.
    Lebkowski, Jane S.
    Rahhal, Firas M.
    Avery, Robert L.
    Salehi-Had, Hani
    Chen, Sanford
    Chan, Clement
    Palejwala, Neal
    Ingram, April
    Dang, Wei
    Lin, Chih-Min
    Mitra, Debbie
    Pennington, Britney O.
    Hinman, Cassidy
    Faynus, Mohamed A.
    Bailey, Jeffrey K.
    Mohan, Sukriti
    Rao, Narsing
    Johnson, Lincoln, V
    Clegg, Dennis O.
    Hinton, David R.
    Humayun, Mark S.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2021, 10 (10):
  • [7] Organelle distribution of the human retinal pigment epithelium (RPE) in age-related macular degeneration (AMD)
    von der Emde, Leon
    Bermond, Katharina
    Tarau, Iona-Sandra
    Bourauel, Leonie
    Heintzmann, Rainer
    Holz, Frank G.
    Curcio, Christine A.
    Sloan, Kenneth R.
    Ach, Thomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [8] Clinically visible progression indicators in age-related macular degeneration (AMD) are transdifferentiated retinal pigment epithelium (RPE)
    Curcio, C. A.
    Leong, B.
    Messinger, J. D.
    Ach, Kar D.
    Yannuzzi, T. L. A.
    Freund, K. B.
    Cao, D.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (08) : A120 - A120
  • [9] Molecular characterization of retinal pigment epithelium (RPE) correlating to hyperreflective foci (HRF) in age-related macular degeneration (AMD)
    Cao, Dongfeng
    Messinger, Jeffrey
    Smith, Roland Theodore
    Ach, Thomas
    Curcio, Christine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [10] Phenotypes of Retinal Pigment Epithelium (RPE) Autofluorescence (AF) and Morphology in Donor Eyes with Age-Related Macular Degeneration (AMD)
    Gambril, John Alan
    Sloan, Kenneth R.
    Huisingh, Carrie E.
    Messinger, Jeffrey D.
    Ach, Thomas
    Curcio, Christine A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345